London, June 12, 2026, 12:02 BST
- Unilever’s London shares were up about 0.9% near 4,391p in Friday trading, broadly tracking a firmer FTSE 100.
- Investors are looking past a quiet news day toward July 28, when Unilever reports Q2 and half-year results.
- The stock looks selectively attractive for income and turnaround investors, but still carries execution and weak-Europe risks.
Unilever PLC shares edged higher on Friday, with the London-listed stock trading around 4,391p, up 0.9%, after opening at 4,348p and touching an intraday high of 4,409p. The move came as the FTSE 100 was also stronger, leaving the stock’s short-term performance tied partly to a broader rebound in large-cap UK equities rather than a single fresh corporate announcement. Hargreaves Lansdown data showed Unilever at a market value of about £95 billion, with a dividend yield close to 4%, while Google Finance showed the stock still well below its 52-week high of 5,542.11p.
The latest price action matters because Unilever has been trying to rebuild investor confidence after a period of portfolio reshaping, cost savings and uneven demand in developed markets. On Wednesday, the shares rose 2.73% to £44.02, outperforming the FTSE 100, according to MarketWatch; Friday’s move suggests buyers are still testing whether the stock’s valuation discount is enough to offset softer growth in Europe and the complexity of the planned Foods transaction.
The strongest bull case rests on volume-led growth, not just price increases. In its first-quarter update, Unilever reported underlying sales growth, or USG, of 3.8%; USG is a non-GAAP measure that strips out currency movements, acquisitions and disposals to show the underlying sales trend. Volume growth was 2.9%, while price contributed 0.9%, a healthier mix because it implies more products sold rather than growth driven mainly by higher prices. CEO Fernando Fernandez said Unilever had “started the year well with volume-led growth driven by our Power Brands” and added that the company “remain confident of delivering on our guidance for the year ahead.”
The bear case is that Unilever still has to prove the improvement can survive slower consumer markets. The company’s own Q1 figures showed Europe down 0.9% on underlying sales, with volumes falling 1.2%, while developed markets grew only 1.0%. Turnover also fell 3.3% to €12.6 billion because currency movements more than offset the underlying growth. Those figures matter for the share price because a consumer staples stock is usually valued for dependable growth; if Europe stays weak or currencies remain a drag, investors may be reluctant to pay a higher multiple.
Capital returns provide some support. Unilever said on June 5 that it had completed a share buyback of up to €1.5 billion, purchasing 30,703,780 ordinary shares for an aggregate market value equivalent of €1,499,999,891. A buyback reduces the share count, which can lift earnings per share — profit divided by the number of shares — if earnings are stable. It does not solve operating weakness, but it can make the equity story more attractive when combined with a near-4% dividend yield.
The next major catalyst is Unilever’s Q2 and half-year 2026 results on July 28. Investors will watch whether the company can keep full-year underlying sales growth at the bottom end of its 4% to 6% multi-year guidance range, deliver at least 2% underlying volume growth, and show progress on margin improvement. The same date also matters because the company is expected to release updated financials reflecting the Ice Cream demerger backdrop, while analysts will refresh consensus estimates after the pre-close material.
Analyst sentiment is supportive but not one-sided. Investors Chronicle data showed 17 analysts with a median 12-month target of 5,204.15p, about 19.6% above a recent 4,352p reference price, with three “buy,” six “outperform,” seven “hold,” one “sell” and one “strong sell” recommendations as of June 4. MarketScreener also listed recent “Buy” calls from Barclays on June 10 and JP Morgan on June 9, but its wider consensus still showed downside risk in the lowest target. Investors Chronicle
At today’s price, Unilever looks more attractive than risky for patient income investors, but not a clear bargain for everyone. The bull case is a combination of volume recovery, portfolio simplification, buyback support and a dividend yield near 4%. The bear case is that weak European demand, currency pressure, commodity costs and execution risk around the McCormick Foods combination could keep the stock range-bound. Until the July 28 results show whether Q1 volume momentum is continuing, the shares appear reasonably valued with selective upside rather than obviously cheap.
